SCTV01E-1

· Sinocelltech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCTV01E-1, covering 2022-08-31 to 2022-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years [Phase 2]

See pricing